Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.43 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.43 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.42 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.42 |
| ▸ | PTPN12 | Q05209 | 1/20 | 0.42 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 3/20 | 0.42 |
| ▸ | MAOB | P27338 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | EDNRA | P25101 | 1/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20372684 | 0.90 | GPR3 (0.47) | GPR3MAPTALDH1A1HPGDRAB9A | |
| SCHEMBL15836071 | 0.87 | GPR3 (0.52) | GPR3MAPTALDH1A1HPGDRAB9A | |
| SCHEMBL29363890 | 0.86 | KDM4E (0.58) | GPR3MAPTALDH1A1HPGDRAB9A | |
| SCHEMBL18636119 | 0.86 | KDM4E (0.58) | GPR3MAPTALDH1A1HPGDRAB9A | |
| SCHEMBL1128376 | 0.86 | KDM4E (0.58) | GPR3MAPTALDH1A1HPGDRAB9A | |
| SCHEMBL31012433 | 0.86 | KDM4E (0.58) | GPR3MAPTALDH1A1HPGDRAB9A | |
| SCHEMBL16709677 | 0.83 | GPR3 (0.44) | GPR3MAPTALDH1A1HPGDRAB9A | |
| Dibenzothiophene SCHEMBL9160414 | 0.83 | GPR3 (0.52) | GPR3MAPTALDH1A1HPGDRAB9A | |
| SCHEMBL21300699 | 0.81 | KDM4E (0.62) | GPR3MAPTALDH1A1HPGDRAB9A | |
| SCHEMBL28018269 | 0.81 | GPR3 (0.54) | GPR3MAPTALDH1A1HPGDRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3498691-B1 | NOVEL CATIONIC PHOTOINITIATOR, AND PREPARATION METHOD THEREFOR AND APPLICATIONS THEREOF | CHANGZHOU TRONLY NEW ELECTRONIC MAT CO LTD (CN) | 2021-07-07 | — | — | EP | disclosed |
| US-10995082-B2 | Cationic photoinitiator and preparation method and use thereof | CHANGZHOU TRONLY NEW ELECTRONIC MATERIALS CO., LTD. (CN) | 2021-05-04 | — | — | US | disclosed |
| US-20190218199-A1 | NOVEL CATIONIC PHOTOINITIATOR AND PREPARATION METHOD AND USE THEREOF | CHANGZHOU TRONLY ADVANCED ELECTRONIC MATERIALS CO., LTD. (CN) | 2019-07-18 | — | — | US | disclosed |
| EP-3498691-A1 | NOVEL CATIONIC PHOTOINITIATOR, AND PREPARATION METHOD THEREFOR AND APPLICATIONS THEREOF | Changzhou Tronly New Electronic Materials Co., Ltd (CN) | 2019-06-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10995082-B2 | Cationic photoinitiator and preparation method and use thereof | SLC11A2, SLC7A1, PPOX | GPR3 2968/4885MAPT 1573/4885ALDH1A1 3153/4885 |
| US-20190218199-A1 | NOVEL CATIONIC PHOTOINITIATOR AND PREPARATION METHOD AND USE THEREOF | SLC11A2, SLC7A1, PPOX | GPR3 3180/4885MAPT 1723/4885ALDH1A1 2798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.